The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
National Survey of Pharmacists 2006: Full Topline Results These toplines provide additional findings from a 2006 national survey of pharmacists on their views and experiences on a wide range of health care issues. Toplines (.
Two Kaiser Family Foundation national surveys of doctors and pharmacists examine additional findings on their views and experiences on a wide range of health care issues.
National Survey of Physicians 2006: Full Topline Results These toplines provide additional findings from a 2006 national survey of physicians on their views and experiences on a wide range of health care issues. Toplines (.
This paper describes the various steps of the Medicare Part D appeals process for obtaining necessary drugs not on a plan’s formulary. Using case reports collected from a network of beneficiary advocates, it illustrates the challenges and problems some beneficiaries encountered when navigating this aspect of the drug benefit.
These toplines provide the results of a 2006 national survey of physicians on their views and experiences related to the new Medicare drug benefit. Topline (.
These toplines provide the results of a 2006 national survey of pharmacists on their views and experiences related to the new Medicare drug benefit. Topline (.
Two national surveys conducted and analyzed by the Kaiser Family Foundation show that substantial majorities of pharmacists and physicians believe that the prescription drug law is helping people on Medicare save money on their medications.
This document highlights key data from separate surveys of pharmacists and physicians related to the new Medicare drug benefit. Chartpack (.
This report offers insights into Medicare beneficiaries’ experiences with the new drug benefit, based on observations of State Health Insurance Assistance Plan (SHIP) directors convened for a moderated focus group discussion.
The Kaiser Family Foundation released a new report on the implications of the new Medicare Part D prescription drug benefit for people living with HIV/AIDS. The report looks at the coverage and cost of antiretroviral drugs under the new private, stand-alone Medicare drug plans. Report (.
© 2025 KFF